Out of 5 analysts covering Mannkind (NASDAQ:MNKD), 2 rate it “Buy”, 4 “Sell”, while 1 “Hold”. This means 29% are positive. Mannkind was the topic in 7 analyst reports since August 3, 2015 according to StockzIntelligence Inc. Below is a list of MannKind Corporation (NASDAQ:MNKD) latest ratings and price target changes.
06/01/2016 Broker: Piper Jaffray Rating: Underweight Old Target: $1.5 New Target: $0.05 Maintain
06/01/2016 Broker: RBC Capital Markets Rating: Underperform Old Target: $1 New Target: $0.15 Maintain
16/11/2015 Broker: Griffin Securities Old Rating: Buy New Rating: Neutral Downgrade
04/11/2015 Broker: RBC Capital Markets Old Rating: Outperform New Rating: Underperform Old Target: $9 New Target: $1 Downgrade
About 3.02M shares traded hands. MannKind Corporation (NASDAQ:MNKD) has declined 70.88% since August 5, 2015 and is downtrending. It has underperformed by 65.63% the S&P500.
MannKind Corporation is a biopharmaceutical firm focused on the discovery and development of therapeutic products for diseases, such as diabetes. The company has a market cap of $573.07 million. The Company’s product candidate is AFREZZA, inhaled insulin used to control high blood sugar in adults with type one and type two diabetes and also to improve glycemic control. It currently has negative earnings. AFREZZA consists of a dry formulation of human insulin delivered from a small and portable inhaler.
The institutional sentiment decreased to 1.04 in Q3 2015. Its down 0.23, from 1.27 in 2015Q2. The ratio turned negative, as 38 funds sold all MannKind Corporation shares owned while 39 reduced positions. 25 funds bought stakes while 55 increased positions. They now own 89.26 million shares or 32.31% less from 131.87 million shares in 2015Q2.
Greywolf Capital Management Lp holds 4.78% of its portfolio in MannKind Corporation for 9.08 million shares. Aym Capital Llc owns 154,000 shares or 1.81% of their US portfolio. Moreover, National Asset Management Inc. has 0.51% invested in the company for 663,089 shares. The California-based Old West Investment Management Llc has invested 0.44% in the stock. Bolton Lp, a Connecticut-based fund reported 786,000 shares.
MannKind Corporation - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.